Medpace Holdings Inc
Gesloten
SectorGezondheidszorg
456.02 -0.71
Overzicht
Wijziging aandelenprijs
24u
Min
453.27
Max
466.42
Inkomsten | -11M 124M |
|---|---|
Verkoop | -1.8M 707M |
K/W Sectorgemiddelde | 29.031 49.712 |
EPS | 4.28 |
Winstmarge | 17.53 |
Werknemers | 6,300 |
EBITDA | -9.5M 154M |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | -2.03% downside |
Volgende Winsten | 22 jul 2026 |
|---|
Marktkapitalisatie | -1.9B 13B |
|---|---|
Vorige openingsprijs | 456.73 |
Vorige sluitingsprijs | 456.02 |
Nieuwssentiment
By Acuity
50%
50%
155 / 342 Rangschikking in Healthcare
Medpace Holdings Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.